Blood Transfusion Diagnostics Market is Growing at a CAGR of 7% by 2032

The market of blood transfusion diagnostics is predicted to grow at a CAGR of 7% from USD 4.73 billion in 2022 to USD 8.7 billion in 2032. The increase in CAGR is due to this market's demand and economic expansion, Blood transfusion diagnostics refers to tests conducted on blood and blood components prior to transfusion to patients.

The increasing prevalence of blood-related ailments such as hemophilia, cancer, thrombocytopenia, and others, as well as chronic kidney disease (CKD), has expanded the market for blood products and total blood transfusion. The adoption of innovative molecular platforms by leading companies accelerates the transition from manual tests and equipment to semi-automated and fully automated devices. The introduction of such sophisticated automated systems has aided in the implementation of blood transfusion diagnostics and is anticipated to propel market expansion over the forecast period.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 -https://www.factmr.com/connectus/sample?flag=S&rep_id=4720?PS

North America is set to maintain its position as the world leader in blood transfusion diagnostics. A high proportion of voluntary blood donors, as well as the integration of blood transfusion policies for safety and communicable disease testing, are critical growth factors. Germany and the United Kingdom are major contributors to the European blood transfusion diagnostics market. The growing number of surgeries and transplantation methods can be attributed to the industry progress in these nations.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

Asia-Pacific is predicted to grow the quickest, with a CAGR of 7.0%
The North American market is projected to grow at a favorable CAGR of 6.4%
During the projected period, the blood grouping segment will expand at a CAGR of 5.8%.
China's National Health Commission registered 15.53 million blood donations in 2020.
The Europe market is projected to expand at a favorable CAGR of 6.6%

"Chronic diseases, such as cancer, cardiovascular disease, and renal disorders, are typically treated through surgical procedures, which are linked to an increased likelihood of excessive blood loss, and are driving the market growth." says a Fact.MR analyst.

𝐁𝐥𝐨𝐨𝐝 𝐓𝐫𝐚𝐧𝐬𝐟𝐮𝐬𝐢𝐨𝐧 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

Fact.MR has studied the blood transfusion diagnostics market with detailed segmentation on the basis of product type, application, end-user and geography.

By Product Type :

Instruments
Kits & Reagents

By Application :

Blood Grouping
Disease Screening
Molecular Disease Screening
Serological Disease Screening

By End-user :

Hospitals
Diagnostic Laboratories
Blood Banks
Plasma Fractionation Companies
Others

By Geography :

North America
Europe
Asia Pacific
Eastern Europe
Latin America
Middle East & Africa (MEA)

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 -https://www.factmr.com/connectus/sample?flag=RC&rep_id=4720?PS

𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧

Grifols S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., CSL Ltd., Abbott Laboratories, F. Hoffmann-La Roche Ltd, QUOTIENT, Merck KGaA, and DiaSorin S.p.A. are the leading market players in the global blood transfusion diagnostics market. These market participants are focused on implementing technological breakthroughs in testing procedures. Plasma fractionation is an example of such technological advancement.

• In October 2019, Ortho Clinical Diagnostics declared FDA approval for the usage of Ortho Sera on its VISION analyzer.
• EryPharm entered the market in April 2021 with an advanced technology that can produce red blood cells in large quantities and build innovative blood transfusion sources.
• F. Hoffmann-La Roche Ltd and Bio-Rad Laboratories, Inc. signed a global partnership agreement in March 2021 to provide customers with access to Bio-full Rad's line of InteliQ products and Unity QC data management solutions.

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞

Fact.MR, in its new offering, presents an unbiased analysis of the chromatography syringes market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032.

The study divulges essential insights on the market on the basis of, Product Type (Instruments, Kits & Reagents), By Application (Blood Grouping, Molecular Disease Screening), By End-user (Hospitals, Diagnostic Laboratories, Blood Banks), across seven major regions of the world (North America, Latin America, Europe, Asia Pacifc and the Middle East & Africa).

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.